Learn More
Mazzucchelli et al. (1) are incorrect in stating that the recently updated American Diabetes Association (ADA)/European Association for the Study of Diabetes (EASD) Position Statement on the(More)
To fate of exogenous glucagon-like peptide I (GLP-I)(7-36) amide was studied in nondiabetic and type II diabetic subjects using a combination of high-pressure liquid chromatography (HPLC), specific(More)
AIM To compare the efficacy and safety of sitagliptin vs. glipizide in patients with type 2 diabetes and inadequate glycaemic control [haemoglobin A(1c) (HbA(1c)) > or = 6.5 and < or = 10%] on(More)